Literature DB >> 10695592

Risk factors for a causal intermediate and an endpoint: reconciling differences.

M B Terry1, A I Neugut, S Schwartz, E Susser.   

Abstract

When a risk factor influences the intermediary but not progression to the endpoint, it has been shown that the relative risk estimate for the causal intermediate is identical to that for the endpoint under a single pathway framework. When there are multiple pathways, the relative risk estimate for the endpoint is reduced. The authors examine how the reduction of the effect size from a risk factor's association with the causal intermediate to that with the endpoint relates to the proportion of endpoint cases arising through other pathways, and the measure of effect used. For multiple pathways, all measures of effect are reduced and the reduction increases as the proportion of endpoint cases arising through other pathways increases. For single pathways, the relative rate ratio and odds ratios are reduced. In particular, the reduction in the odds ratio may be dramatic because of the commonness of causal intermediates relative to the endpoint. Comparisons of causal intermediate studies with those for the endpoint should consider the influences of multiple pathways, the prevalence of the causal intermediate, the measure of effect used, and the multiple effects a risk factor may have along the pathway when interpreting the differences observed across the causal chain.

Mesh:

Year:  2000        PMID: 10695592     DOI: 10.1093/oxfordjournals.aje.a010212

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

1.  Vegetable and fruit intakes and risk of Barrett's esophagus in men and women.

Authors:  Olivia M Thompson; Shirley A A Beresford; Elizabeth A Kirk; Thomas L Vaughan
Journal:  Am J Clin Nutr       Date:  2009-01-14       Impact factor: 7.045

2.  Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer.

Authors:  Ikuko Kato; Federico Canzian; Martyn Plummer; Silvia Franceschi; Leen-Jan van Doorn; Jorge Vivas; Gladys Lopez; Yanhui Lu; Lydie Gioia-Patricola; Richard K Severson; Ann G Schwartz; Nubia Muñoz
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

3.  A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation.

Authors:  Jay S Kaufman; Richard F Maclehose; Sol Kaufman
Journal:  Epidemiol Perspect Innov       Date:  2004-10-08

4.  Mutations in p53, p53 protein overexpression and breast cancer survival.

Authors:  Pavel Rossner; Marilie D Gammon; Yu-Jing Zhang; Mary Beth Terry; Hanina Hibshoosh; Lorenzo Memeo; Mahesh Mansukhani; Chang-Min Long; Gail Garbowski; Meenakshi Agrawal; Tara S Kalra; Mia M Gaudet; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  J Cell Mol Med       Date:  2008-10-16       Impact factor: 5.310

5.  Partitioning the population attributable fraction for a sequential chain of effects.

Authors:  Craig A Mason; Shihfen Tu
Journal:  Epidemiol Perspect Innov       Date:  2008-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.